A randomized, multi-centre, double-blind, double dummy placebo controlled single-dose cross-over study to demonstrate that 12 and 24 microg of formoterol delivered by Concept1 has a bronchodilator efficacy which is equivalent to the same dose of formoterol delivered by Aerolizer in adult patients with persistent asthma.
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Novartis
- 24 Oct 2011 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
- 14 Jun 2007 Status changed from in progress to completed.
- 10 Apr 2007 New trial record.